Scheme of pharmacotherapy

Scheme of pharmacotherapy. If the theraphy was terminated or changed (e.g., dosage reduced), “Other” shall be selected. When Other option is selected for pharmacotherapy scheme, the plain text description shall be provided. The plain text must include at least the chemical compounds used, the dosage and timing is optional

Outdated

Validation

Permitted value Language Designation Definition
Scheme of pharmacotherapy - Only preoperatively (no standard): 5-FU 250 mg/m2 i.v. continuous infusion on days 1-13 nad 22-35 and oxaliplatin 50mg/m2 i.v. day 1,8,22 and 29 EN Only preoperatively (no standard): 5-FU 250 mg/m2 i.v. continuous infusion on days 1-13 nad 22-35 and oxaliplatin 50mg/m2 i.v. day 1,8,22 and 29 Scheme of pharmacotherapy - Only preoperatively (no standard): 5-FU 250 mg/m2 i.v. continuous infusion on days 1-13 nad 22-35 and oxaliplatin 50mg/m2 i.v. day 1,8,22 and 29
Scheme of pharmacotherapy - UFT (300-340mg/m2/day) and LV (22.5-90 mg/day) po continuously, 5(-7) days per week, together with radiotherapy EN UFT (300-340mg/m2/day) and LV (22.5-90 mg/day) po continuously, 5(-7) days per week, together with radiotherapy Scheme of pharmacotherapy - UFT (300-340mg/m2/day) and LV (22.5-90 mg/day) po continuously, 5(-7) days per week, together with radiotherapy
Scheme of pharmacotherapy - Capecitabine 800-825 mg/m2 bid po, day 1-5, together with radiation or continuously untill end of radiation EN Capecitabine 800-825 mg/m2 bid po, day 1-5, together with radiation or continuously untill end of radiation Scheme of pharmacotherapy - Capecitabine 800-825 mg/m2 bid po, day 1-5, together with radiation or continuously untill end of radiation
Scheme of pharmacotherapy - 5-FU 1000 mg/m2 i.v. continuous infusion, day 1-5, weeks 1 and 5 EN 5-FU 1000 mg/m2 i.v. continuous infusion, day 1-5, weeks 1 and 5 Scheme of pharmacotherapy - 5-FU 1000 mg/m2 i.v. continuous infusion, day 1-5, weeks 1 and 5
Scheme of pharmacotherapy - 5-FU 225 mg/m2 i.v. continuous infusion, 5 days per week EN 5-FU 225 mg/m2 i.v. continuous infusion, 5 days per week Scheme of pharmacotherapy - 5-FU 225 mg/m2 i.v. continuous infusion, 5 days per week
Scheme of pharmacotherapy - 5-FU 400 mg/m2 + 100 mg i.v. bolus, d 1,2, 11,12,21,22 EN 5-FU 400 mg/m2 + 100 mg i.v. bolus, d 1,2, 11,12,21,22 Scheme of pharmacotherapy - 5-FU 400 mg/m2 + 100 mg i.v. bolus, d 1,2, 11,12,21,22
Scheme of pharmacotherapy - 5-FU 325-350 mg/m2 + LV 20 mg/m2i.v. bolus, day1-5, weeks 1 and 5 EN 5-FU 325-350 mg/m2 + LV 20 mg/m2i.v. bolus, day1-5, weeks 1 and 5 Scheme of pharmacotherapy - 5-FU 325-350 mg/m2 + LV 20 mg/m2i.v. bolus, day1-5, weeks 1 and 5
Other EN Other A scheme of pharmacotherapy which is not mentioned elsewhere on this list

Slots

Name Value
Level REQUIRED
Label PHARMACOTHERAPY_SCHEME